<
Laureate of the four medicines of the stone four medicines of Lijun International
Release time: 2010-12-01 & nbsp & nbsp & nbsp Source:

Newspaper News Lijun International Pharmaceutical (Holdings) Co., Ltd. (Hong Kong stock code: 2005) officially announced on October 29,It costs 90 million yuan to acquire Stake Sports Betting60%of My stake betting appthe equity of Jilin Tonghua Dongbao Drumping business,Establishment of Jilinli Jun Dongbao Pharmaceutical Co., Ltd.,Give full play to the infusion brand and technical advantage of Shijiazhuang Four Pharmaceutical Co., Ltd.,Promotion through transformation,Make it produce the production capacity of the infusion of 100 million bags of soft bags an annual output。This measure marks the brand and technical advantage of Li Jun International with the brand and technical advantage of Shijiazhuang,A solid first step in implementing the expansion of the infusion production expansion。

The stone four medicines owned by Lijun International have more than 60 years of pharmaceutical history,is one of the domestic large infusion manufacturers,The production scale of its single factory ranks first in China,For the production of soft packaging infusion such as soft packaging in plastic bottles and multi -layer co -squeezing films、Quality、Equipment、Technology、Cost、R & D、Overwhelming performance Stake Sports Bettingin stake sports betting appmanagement,It has always been called by the industry,undertake and complete the country、Hebei Province "Eleventh Five -Year Plan" technology support plan key topic "Drugs and Packaging Material Compatibility Safety Research" verification and other scientific research tasks,Known as infusion production、R & D flagship enterprise。2009,Shi Four Pharmaceutical "Shimen Shimen" trademark was identified by the State Administration for Industry and Commerce as a well -known trademark in the domestic infusion industry。With the completion of the new modern preparation project of Shi Four Medicine at the end of this year,The total production capacity of its infusion will reach 1 billion bottles (bags)/year or more,accounting for about 10%of the domestic market。With its leading advantage with its packaging technology,The production and sales ratio of the infusion of glass bottle will be reduced to less than 20%,Reaching the development level of developed countries in Europe and Stake Sports Bettingthe stake sports betting appUnited States in advance。

According to industry analysis,The two parties work together to seek a win -win move for development and revitalizing assets,Lijun International acquired Tonghua Dongbao's large infusion business,Fully rely on the advantages of Tonghua Dongbao in various pulses in the three eastern provinces,Make its stone four medicines in a short period of time in a short period of time.,and strive to occupy the dominant position of the infusion market。Subsequent,Starting in Northwest、South China and other markets "Poor Layout",Its strategic intention is self -explanatory。After acquisition、Reconstruction、Upgrade and expansion of a series of "action",The scale of the infusion of stone four medicines gradually becomes strong。

(Shi Jianhui)